Troy, Emma
Shrukalla, Arif A.
Buture, Alina
Conaty, Katie
Macken, Esther
Lonergan, Roisin
Melling, Jane
Long, Niamh
Shaikh, Eamonn
Birrane, Kieran
Tomkins, Esther M.
Goadsby, Peter J.
Ruttledge, Martin H.
Article History
Received: 19 November 2022
Accepted: 17 December 2022
First Online: 16 January 2023
Declarations
:
: Not Applicable. The datasets used and/or analyzed in this manuscript come from the completion of an audit which was registered in the hospitals where patients were seen. Verbal informed consent was obtained from all patients.
: Not Applicable.
: ET: “No Conflict”.AS: “No Conflict”.AB: has received a PhD Scholarship from the Headache Clinical Trial Funds at the Hull University Teaching Hospitals NHS Trust, UK, and honorarium as a speaker from Novartis and conference travel grant from Eli Lilly.KC: “No Conflict”.EM: “No Conflict”.RL: “No Conflict”.JM: “No Conflict”.NL: “No Conflict”.ES: has received honoraria from Teva.KB: has received personal fees from Novartis.EMT: has received personal fees and/or honoraria from Allegran/Abbvie, Pfizer, Novartis, Teva, and Lundbeck.PJG: reports, over the last 36 months, grants and personal fees from Eli-Lilly and Company, grant from Celgene, and personal fees from Aeon Biopharma, Allergan/Abbvie, Amgen, Biodelivery Sciences International, Biohaven Pharmaceuticals Inc., CoolTech LLC, Dr Reddys, Epalex, GlaxoSmithKline, Impel Neuropharma, Lundbeck, Novartis, Praxis, Sanofi, Satsuma, and Teva Pharmaceuticals, and personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, Vector Metric, and fees for educational materials from CME Outfitters, Omnia Education, WebMD, and publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate and Wolters Kluwer, and for medicolegal advice in headache, and a patent magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee. MR: has received personal fees and/or honoraria from Allegran/Abbvie, Pfizer, Grunenthal, Eli-Lilly, Novartis, Teva, Lundbeck and MSD.